510(k) Report

510(k) · Cleared

Cleared

Cora (Coagulation Resonance Analysis) System with Platelet Mapping Assay

K140893510(k) TraditionalCleared Jan 3, 2015270-day reviewClass II21 CFR 864.5700

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Coramed Technologies, LLC · JOZ System, Automated Platelet Aggregation

Cleared on Jan 3, 2015 as substantially equivalent to K041502 (Haemoscope Corp., 2004) after a 270-day review. Its family tree reaches back 1 generation to 2004.

Decided
Jan 3, 2015
Review
270 days
Class
Class II
Product code
JOZ
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K041502 (2004). No later device cites it as a predicate yet.

K041502 · Thrombelastograph (Teg) Platelet Mapping Assay · Haemoscope Corp. · 2004 · recalled2000200520102015
  1. Root · 1 generation backK041502 Thrombelastograph (Teg) Platelet Mapping AssayHaemoscope Corp. · 2004 · Recalled
  2. This deviceK140893 Cora (Coagulation Resonance Analysis) System with Platelet Mapping…Coramed Technologies, LLC · 2015
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K041502Thrombelastograph (Teg) Platelet Mapping AssayHaemoscope Corp.20041
0 (this device)K140893Cora (Coagulation Resonance Analysis) System with Platelet Mapping AssayCoramed Technologies, LLC2015—
FIG. 1 — Lineage of K140893, 2004–2015Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in JOZ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new JOZ device

  1. #1 K191364 T-TAS 01 Total Thrombus-formation Analysis…score -0.6 · 3 generations · no Class I recall
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K041502Thrombelastograph (Teg) Platelet Mapping Assay
Summary page 4
…ood Hemostasis System Classification Name: 21CFR 864.5700 Automated Platelet Aggregation System PREDICATE DEVICE o Thrombelastograph® (TEG® PlateletMapping Assay), K041502, Product Code JOZ (System, Automated Platelet Aggregation), Haemoscope Corporation CORA System PlateletMap…
Haemoscope Corp.20041

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has a recall.

How does its category compare?

All JOZ devices

JOZ System, Automated Platelet Aggregation: FDA decisions, review times, recalls and adverse event reports over 20 years. 2015, this device’s year, is highlighted.

FDA decisions per year · JOZ

1in 2020

2012: 12013: 12015: 22016: 12017: 12019: 12020: 1
2007high 2 (2015) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · JOZ

Too few JOZ 510(k)s in any year since 2007 to give a median.

Recalls per year · JOZ

1in 2025

2013: 12024: 12025: 1
2007high 1 (2013) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · JOZ

3in 2025

2010: 12012: 12013: 12014: 12017: 12018: 252019: 92020: 22021: 22022: 162024: 12025: 3
2007high 25 (2018) · low 0 (2007)2025

MAUDE reports naming product code JOZ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—01
20110—00
20121—01
20131—11
20140—01
20152—00
20161—00
20171—01
20180—025
20191—09
20201—02
20210—02
20220—016
20230—00
20240—11
20250—13
20260—0—

What is it indicated for?

The CORA PlateletMapping System consists of the CORA analyzer and the CORA PlateletMapping Assay Cartridge. The CORA Platelet Mapping System is intended for in vitro diagnostic use to provide qualitative assessment of platelet function. The CORA System records the kinetic changes in a sample of heparinized whole blood as the sample clots. The CORA System PlateletMapping Assay Cartridge provides four channels of dried-in-place reagents, HKH (Kaolin with…

Read the full statement (187 words)

The CORA PlateletMapping System consists of the CORA analyzer and the CORA PlateletMapping Assay Cartridge. The CORA Platelet Mapping System is intended for in vitro diagnostic use to provide qualitative assessment of platelet function. The CORA System records the kinetic changes in a sample of heparinized whole blood as the sample clots.

The CORA System PlateletMapping Assay Cartridge provides four channels of dried-in-place reagents, HKH (Kaolin with Heparinase), Activator F, AA and ADP (one reagent in each channel). In combination, MA parameter results from these four reagents are used to calculate the parameters platelet % Inhibition and % Aggregation for AA and ADP.

Results from the CORA analysis should not be the sole basis for a patient diagnosis, but should be evaluated together with the patient’s medical history, the clinical picture and, if necessary, further hemostasis tests.

The CORA System with CORA PlateletMapping Assay Cartridge is indicated for use with adult patients where an evaluation of their blood hemostasis properties is desired. Hemostasis evaluation with the CORA PlateletMapping System is used to assess clinical conditions in cardiovascular surgery and cardiology procedures to assess hemorrhage or thrombosis conditions.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K140893: Cora (Coagulation Resonance Analysis) System with Platelet Mapping Assay.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K140893

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026